Literature DB >> 24837502

Challenges in vaccination of neonates, infants and young children.

Michael E Pichichero1.   

Abstract

All neonates, infants and young children receive multiple priming doses and booster vaccinations in the 1st and 2nd year of life to prevent infections by viral and bacterial pathogens. Despite high vaccine compliance, outbreaks of vaccine-preventable infections are occurring worldwide. These data strongly argue for an improved understanding of the immune responses of neonates, infants and young children to vaccine antigens and further study of the exploitable mechanisms to achieve more robust and prolonged immunity with fewer primary and booster vaccinations in the pediatric population. This review will focus on our recent work involving infant and young child immunity following routine recommended vaccinations. The discussion will address vaccine responses with respect to four areas: (1) systemic antibody responses, (2) memory B-cell generation, (3) CD4 T-cell responses, and (4) APC function.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen presenting cells; B cells; B-cell receptor; CD4 T-cells; Children; Dendritic cells; Haemophilus influenzae; Infants; MHC II; Neonate; Streptococcus pneumoniae; T cells; T-cell receptor; Toll-like receptor; Vaccination; cytokines; immunologic memory; pediatric vaccines

Mesh:

Substances:

Year:  2014        PMID: 24837502      PMCID: PMC4135535          DOI: 10.1016/j.vaccine.2014.05.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  98 in total

1.  Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.

Authors:  D Viemann; P Schlenke; H J Hammers; H Kirchner; A Kruse
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

2.  The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells.

Authors:  A K Somani; K Yuen; F Xu; J Zhang; D R Branch; K A Siminovitch
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

3.  IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death.

Authors:  Rose M O'Neill; Jaythoon Hassan; Denis J Reen
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

4.  IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2.

Authors:  Lequn Li; Hyun-Hee Lee; J Jeremiah Bell; Randal K Gregg; Jason S Ellis; Andre Gessner; Habib Zaghouani
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  Neonatal CD8+ T-cell differentiation is dependent on interleukin-12.

Authors:  Mark J McCarron; Denis J Reen
Journal:  Hum Immunol       Date:  2010-09-16       Impact factor: 2.850

Review 6.  Cellular immune response in young children accounts for recurrent acute otitis media.

Authors:  Sharad K Sharma; Michael E Pichichero
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

7.  Reducing the frequency of acute otitis media by individualized care.

Authors:  Michael E Pichichero; Janet R Casey; Anthony Almudevar
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

8.  Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.

Authors:  M E Belderbos; G M van Bleek; O Levy; M O Blanken; M L Houben; L Schuijff; J L L Kimpen; L Bont
Journal:  Clin Immunol       Date:  2009-08-03       Impact factor: 3.969

9.  Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

Authors:  S K Sharma; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 10.  Accelerating next-generation vaccine development for global disease prevention.

Authors:  Wayne C Koff; Dennis R Burton; Philip R Johnson; Bruce D Walker; Charles R King; Gary J Nabel; Rafi Ahmed; Maharaj K Bhan; Stanley A Plotkin
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

View more
  21 in total

Review 1.  The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

Authors:  M Nadeem Khan; Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Neonatal Vaccination: Challenges and Intervention Strategies.

Authors:  Matthew C Morris; Naveen Surendran
Journal:  Neonatology       Date:  2016-01-13       Impact factor: 4.035

Review 3.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

4.  Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.

Authors:  M Nadeem Khan; Qingfu Xu; Michael E Pichichero
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

5.  Targeting Antigens to CD180 but Not CD40 Programs Immature and Mature B Cell Subsets to Become Efficient APCs.

Authors:  Kelsey Roe; Geraldine L Shu; Kevin E Draves; Daniela Giordano; Marion Pepper; Edward A Clark
Journal:  J Immunol       Date:  2019-09-04       Impact factor: 5.422

6.  Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children.

Authors:  Jing Cheng; Tamar Ringel-Kulka; Ineke Heikamp-de Jong; Yehuda Ringel; Ian Carroll; Willem M de Vos; Jarkko Salojärvi; Reetta Satokari
Journal:  ISME J       Date:  2015-10-02       Impact factor: 10.302

Review 7.  The virology of breast cancer: viruses as the potential causative agents of breast tumorigenesis.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2019-03       Impact factor: 2.970

8.  Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.

Authors:  Beth C Holbrook; Ralph B D'Agostino; S Tyler Aycock; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Vaccine       Date:  2017-09-28       Impact factor: 3.641

Review 9.  The immune system in infants: Relevance to xenotransplantation.

Authors:  Mohamed Bikhet; Mahmoud Morsi; Hidetaka Hara; Leslie A Rhodes; Waldemar F Carlo; David Cleveland; David K C Cooper; Hayato Iwase
Journal:  Pediatr Transplant       Date:  2020-08-26

10.  Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women.

Authors:  Tino F Schwarz; Casey Johnson; Christine Grigat; Dan Apter; Peter Csonka; Niklas Lindblad; Thi Lien-Anh Nguyen; Feng F Gao; Hui Qian; Antonella N Tullio; Ilse Dieussaert; Marta Picciolato; Ouzama Henry
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.